Rodríguez Ester, Romero Carolina, Río Adolfo, Miralles Marta, Raventós Aida, Planells Laura, Burgueño Joan F, Hamada Hirofumi, Perales Jose Carlos, Bosch Assumpció, Gassull Miguel Angel, Fernández Ester, Chillon Miguel
Centre de Biotecnologia Animal i Teràpia Gènica (CBATEG), Departament Bioquímica i Biologia Molecular, Universitat Autònoma Barcelona, Barcelona 08193, Spain.
Hum Gene Ther Methods. 2013 Aug;24(4):195-204. doi: 10.1089/hgtb.2012.096. Epub 2013 Jun 27.
The lack of vectors for selective gene delivery to the intestine has hampered the development of gene therapy strategies for intestinal diseases. We hypothesized that chimeric adenoviruses of Ad5 (species C) displaying proteins of the naturally enteric Ad40 (species F) might hold the intestinal tropism of the species F and thus be useful for gene delivery to the intestine. As oral-fecal dissemination of enteric adenovirus must withstand the conditions encountered in the gastrointestinal tract, we studied the resistance of chimeric Ad5 carrying the short-fiber protein of Ad40 to acid milieu and proteases and found that the Ad40 short fiber confers resistance to inactivation in acidic conditions and that AdF/40S was further activated upon exposure to low pH. In contrast, the chimeric AdF/40S exhibited only a slightly higher protease resistance compared with Ad5 to proteases present in simulated gastric juice. Then, the biodistribution of different chimeric adenoviruses by oral, rectal, and intravenous routes was tested. Expression of reporter β-galactosidase was measured in extracts of 15 different organs 3 days after administration. Our results indicate that among the chimeric viruses, only intrarectally given AdF/40S infected the colon (preferentially enteroendocrine cells and macrophages) and to a lesser extent, the small intestine, whereas Ad5 infectivity was very poor in all tissues. Additional in vitro experiments showed improved infectivity of AdF/40S also in different human epithelial cell lines. Therefore, our results point at the chimeric adenovirus AdF/40S as an interesting vector for selective gene delivery to treat intestinal diseases.
缺乏用于将基因选择性递送至肠道的载体阻碍了肠道疾病基因治疗策略的发展。我们推测,展示天然肠道腺病毒Ad40(F种)蛋白的Ad5(C种)嵌合腺病毒可能具有F种的肠道嗜性,因此可用于将基因递送至肠道。由于肠道腺病毒的粪口传播必须耐受胃肠道中遇到的条件,我们研究了携带Ad40短纤维蛋白的嵌合Ad5对酸性环境和蛋白酶的抗性,发现Ad40短纤维赋予了在酸性条件下抗灭活的能力,并且AdF/40S在暴露于低pH值时会进一步被激活。相比之下,与Ad5相比,嵌合AdF/40S对模拟胃液中存在的蛋白酶的抗性仅略高。然后,测试了不同嵌合腺病毒通过口服、直肠和静脉途径的生物分布。在给药3天后,在15个不同器官的提取物中测量报告基因β-半乳糖苷酶的表达。我们的结果表明,在嵌合病毒中,只有经直肠给予的AdF/40S感染了结肠(优先感染肠内分泌细胞和巨噬细胞),在较小程度上感染了小肠,而Ad5在所有组织中的感染性都很差。额外的体外实验表明,AdF/40S在不同的人上皮细胞系中也具有改善的感染性。因此,我们的结果表明嵌合腺病毒AdF/40S是一种用于选择性基因递送以治疗肠道疾病的有趣载体。